経営計画・資本政策の見直し/2025-05-15
実施中
公表資料を発表・実施・結果の順に記録しています。この表示は選定した案件の調査状況であり、会社全体の評価ではありません。
Vista2027 Stage II capital allocation
Nissan Chemical launched a quantified three-year plan; 1Q FY2026 subsequently showed sales and income above prior-year and internal outlook, led in part by semiconductor materials.
時系列と出典(2件・内容は原文)
- 2025-05-15Stage II announced The company set FY2027 earnings, return, capex, R&D and payout targets. 出典資料1
- 2026-06-30(公表 2026-08-07)First-quarter progress reported Performance Materials sales increased significantly, mainly from semiconductor materials, and consolidated results exceeded prior-year and outlook. 出典資料1
経営陣が表明したこと
Nissan Chemical set FY2027 operating profit of ¥65bn, ROE of 18.5%, ¥79.6bn capex and at least 75% total payout.
会社の開示資料による ・ 出典資料1
実際に行ったこと・時期
1Q FY2026 results exceeded the prior year and internal outlook, with strong semiconductor-material sales.
一部開示(不足あり) ・ 出典資料1
経済性について開示したこと
The plan focuses investment on semiconductor materials and agrochemicals and uses Go/Stop development gates.
一部開示(不足あり) ・ 出典資料1
残る論点
Investor question: How is semiconductor spend converting into qualified products, sales and ROIC? IR preparation: publish a project-cohort capital and returns bridge.
当調査の分析(会社の説明ではありません)